Search Results

There are 33950 results for: content related to: Application of new room-temperature catalytic oxidation material on indoor formaldehyde control

  1. Validation of the doubly-labeled water (DLW) method for estimating CO2 production and water flux in growing poultry chicks

    Journal of Avian Biology

    Volume 35, Issue 1, January 2004, Pages: 71–96, James A. Gessaman, Keith Newgrain and Brian Green

    Version of Record online : 23 SEP 2008, DOI: 10.1111/j.0908-8857.2004.03110.x

  2. You have free access to this content
    Challenges in defining type 2M von Willebrand disease: results from a Canadian cohort study

    Journal of Thrombosis and Haemostasis

    Volume 5, Issue 9, September 2007, Pages: 1914–1922, P. D. JAMES, C. NOTLEY, C. HEGADORN, M.-C. POON, I. WALKER, D. RAPSON, ASSOCIATION OF HEMOPHILIA CLINIC DIRECTORS OF CANADA and D. LILLICRAP

    Version of Record online : 26 JUN 2007, DOI: 10.1111/j.1538-7836.2007.02666.x

  3. Class-specific correlations between protein folding rate, structure-derived, and sequence-derived descriptors

    Proteins: Structure, Function, and Bioinformatics

    Volume 54, Issue 2, 1 February 2004, Pages: 333–341, Igor B. Kuznetsov and Shalom Rackovsky

    Version of Record online : 3 SEP 2003, DOI: 10.1002/prot.10518

  4. Optimal risk-sharing under adverse selection and imperfect risk perception

    Canadian Journal of Economics/Revue canadienne d'économique

    Volume 38, Issue 3, August 2005, Pages: 955–978, Arnold Chassagnon and Bertrand Villeneuve

    Version of Record online : 28 JUL 2005, DOI: 10.1111/j.0008-4085.2005.00311.x

  5. You have free access to this content
    von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)

    Haemophilia

    Volume 14, Issue 2, March 2008, Pages: 171–232, W. L. NICHOLS, M. B. HULTIN, A. H. JAMES, M. J. MANCO-JOHNSON, R. R. MONTGOMERY, T. L. ORTEL, M. E. RICK, J. E. SADLER, M. WEINSTEIN and B. P. YAWN

    Version of Record online : 28 FEB 2008, DOI: 10.1111/j.1365-2516.2007.01643.x

  6. Development of an ELISA method for testing VWF ristocetin cofactor activity with improved sensitivity and reliability in the diagnosis of von Willebrand disease

    European Journal of Haematology

    Volume 88, Issue 5, May 2012, Pages: 439–445, Yiming Zhao, Ying Gu, Shundong Ji, Jianfeng Yang, Ziqian Yu and Changgeng Ruan

    Version of Record online : 15 FEB 2012, DOI: 10.1111/j.1600-0609.2012.01760.x

  7. You have free access to this content
    von Willebrand factor ristocetin cofactor (VWF:RCo) assay: implementation on an automated coagulometer (ACL)

    Journal of Thrombosis and Haemostasis

    Volume 3, Issue 12, December 2005, Pages: 2684–2688, R. REDAELLI, A. R. CORNO, L. BORRONI, G. MOSTARDA, M. NICHELATTI, E. MORRA and F. BAUDO

    Version of Record online : 24 NOV 2005, DOI: 10.1111/j.1538-7836.2005.01628.x

  8. Comparison of von Willebrand factor (VWF) activity levels determined by HemosIL AcuStar assay and HemosIL LIA assay with ristocetin cofactor assay by aggregometry

    Haemophilia

    Volume 22, Issue 3, May 2016, Pages: e200–e207, S. Sagheer, S. Rodgers, O. Yacoub, R. Dauer, S. Mcrae and E. Duncan

    Version of Record online : 14 APR 2016, DOI: 10.1111/hae.12937

  9. You have free access to this content
    The effect of long-range interactions on the secondary structure formation of proteins

    Protein Science

    Volume 14, Issue 8, August 2005, Pages: 1955–1963, Daisuke Kihara

    Version of Record online : 1 JAN 2009, DOI: 10.1110/ps.051479505

  10. Comparison of a new chemiluminescent immunoassay for von Willebrand factor activity with the ristocetin cofactor-induced platelet agglutination method

    Haemophilia

    Volume 19, Issue 6, November 2013, Pages: 920–925, N. Cabrera, A. Moret, P. Caunedo, A. R. Cid, V. Vila, F. España and J. A. Aznar

    Version of Record online : 4 JUN 2013, DOI: 10.1111/hae.12203

  11. Evaluation of an automated method for measuring von Willebrand factor activity in clinical samples without ristocetin

    International Journal of Laboratory Hematology

    Volume 36, Issue 3, June 2014, Pages: 341–351, L. Graf, K. A. Moffat, S. A. Carlino, A. K. C. Chan, A. Iorio, A. Giulivi and C. P. M. Hayward

    Version of Record online : 18 APR 2014, DOI: 10.1111/ijlh.12218

  12. Evaluation of an heterogeneous group of patients with von Willebrand disease using an assay alternative to ristocetin induced platelet agglutination

    Journal of Thrombosis and Haemostasis

    Volume 13, Issue 10, October 2015, Pages: 1806–1814, F. Stufano, L. Baronciani, M. T. Pagliari, F. Franchi, G. Cozzi, I. Garcia-Oya, P. Bucciarelli, M. Boscarino and F. Peyvandi

    Version of Record online : 27 AUG 2015, DOI: 10.1111/jth.13062

  13. Biomimetic Peptide Surfaces That Regulate Adhesion, Spreading, Cytoskeletal Organization, and Mineralization of the Matrix Deposited by Osteoblast-like Cells

    Biotechnology Progress

    Volume 15, Issue 1, 1999, Pages: 19–32, Alireza Rezania and Kevin E. Healy

    Version of Record online : 4 SEP 2008, DOI: 10.1021/bp980083b

  14. You have free access to this content
    Validation of an automated latex particle–enhanced immunoturbidimetric von Willebrand factor activity assay

    Journal of Thrombosis and Haemostasis

    Volume 9, Issue 10, October 2011, Pages: 1993–2002, D. CHEN, J. I. TANGE, B. J. MEYERS, R. K. PRUTHI, W. L. NICHOLS and J. A. HEIT

    Version of Record online : 29 SEP 2011, DOI: 10.1111/j.1538-7836.2011.04460.x

  15. von Willebrand factor/factor VIII concentrate (Humate-P) for management of elective surgery in adults and children with von Willebrand disease

    Haemophilia

    Volume 17, Issue 6, November 2011, Pages: 895–905, J. C. GILL, A. SHAPIRO, L. A. VALENTINO, J. BERNSTEIN, C. FRIEDMAN, W. L. NICHOLS and M. MANCO-JOHNSON

    Version of Record online : 27 APR 2011, DOI: 10.1111/j.1365-2516.2011.02534.x

  16. Assessing the clinical severity of type 1 von Willebrand disease patients with a microchip flow-chamber system

    Journal of Thrombosis and Haemostasis

    Volume 14, Issue 4, April 2016, Pages: 667–674, K. Nogami, K. Ogiwara, K. Yada, Y. Shida, M. Takeyama, H. Yaoi, H. Minami, S. Furukawa, K. Hosokawa and M. Shima

    Version of Record online : 15 MAR 2016, DOI: 10.1111/jth.13273

  17. Software (MSPECTRA) for automatic interpretation of triacylglycerol molecular mass distribution spectra and collision induced dissociation product ion spectra obtained by ammonia negative ion chemical ionization mass spectrometry

    Rapid Communications in Mass Spectrometry

    Volume 15, Issue 13, 15 July 2001, Pages: 1084–1091, J.-P. Kurvinen, P. Rua, O. Sjövall and H. Kallio

    Version of Record online : 6 JUN 2001, DOI: 10.1002/rcm.340

  18. Validation of a new panel of automated chemiluminescence assays for von Willebrand factor antigen and activity in the screening for von Willebrand disease

    International Journal of Laboratory Hematology

    Volume 35, Issue 5, October 2013, Pages: 555–565, C. J. Verfaillie, E. De Witte and K. M. J. Devreese

    Version of Record online : 3 APR 2013, DOI: 10.1111/ijlh.12087

  19. You have free access to this content
    A highly-sensitive plasma von Willebrand factor ristocetin cofactor (VWF:RCo) activity assay by flow cytometry

    Journal of Thrombosis and Haemostasis

    Volume 6, Issue 2, February 2008, Pages: 323–330, D. CHEN, C. A. DAIGH, J. I. HENDRICKSEN, R. K. PRUTHI, W. L. NICHOLS, J. A. HEIT and W. G. OWEN

    Version of Record online : 14 OCT 2009, DOI: 10.1111/j.1538-7836.2008.02845.x

  20. Comparison of several von Willebrand factor (VWF) activity assays for monitoring patients undergoing treatment with VWF/FVIII concentrates: improved performance with a new modified automated method

    Haemophilia

    Volume 21, Issue 6, November 2015, Pages: 837–845, A. Hillarp, K. D. Friedman, D. Adcock-Funk, S. Tiefenbacher, W. L. Nichols, D. Chen, M. Stadler and B. A. Schwartz

    Version of Record online : 14 JUL 2015, DOI: 10.1111/hae.12703